+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
FEMALE
ID05049538

Pilot Study on Liquid Biopsies and Tumor Molecular Profiling to Predict Recurrence in Endometrial Cancer

Led by M.D. Anderson Cancer Center · Updated on 2026-10-07

1000

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are examining how well liquid biopsies can serve as a non-invasive method to detect cancer cells in patients with various types of endometrial cancer. This observational study aims to compare genetic mutations found in blood samples over the course of treatment with those found in the primary tumor. The study also explores immune and RNA profiles of cancer subtypes and tracks disease progression to better understand cancer behavior. Participants provide blood samples for liquid biopsy at several points before hysterectomy, after surgery but before chemotherapy, and after the final chemotherapy cycle. Tissue samples are collected during hysterectomy, and Pap smears may be done before and after surgery. These procedures allow researchers to analyze circulating tumor DNA and other molecular markers throughout the treatment journey. During the study, participants undergo various assessments including blood draws, tissue collection, and Pap smears to monitor genetic changes and immune profiles. Researchers measure the proportion of circulating cell free DNA mutations over about one year. The study involves tracking patients from before surgery through chemotherapy and possibly recurrence, with data collected to better predict cancer progression and recurrence in endometrial cancer patients.

CONDITIONS

Brief Title

Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers

Research Team

P

Pamela T Soliman, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here